Oppenheimer lowered the firm’s price target on Ceva (CEVA) to $30 from $33 and keeps an Outperform rating on the shares. The firm notes Ceva delivered a solid Q4 with record total revenue of $31.1M and robust licensing revenue growth. With the company positioned for accelerating profitability and AI royalty pipeline, Oppenheimer continues to find risk/reward favorable.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CEVA:
